Advantages and Complications of Transvaginal Mesh Surgery

doi:10.12280/gjfckx.20200581

Abstract

Abstract:

With the increasing aging of the society, pelvic organ prolapse (POP) has become a common disease of elderly women.Transvaginal mesh (TVM) surgery, as a kind of minimally invasive surgery through natural channel for the treatment of POP, with the advantages of anatomical reduction, functional recovery and long-term curative effect, is widely used in recent 20 years. However, it has been warned twice by the US Food and Drug Administration (FDA) for mesh-related complications. The International Urogynecological Association/International Continence Society (IUGA/ICS) classification of mesh-related complications includes:exposure and erosion, hematoma, bladder, urethral and bowel injury, infection, chronic pelvic pain, and de novo dyspareunia. Mesh exposure and erosion are most common complications. It is worth thinking about whether transvaginal mesh should be used or not in China.

Key words: Pelvic organ prolapse, Vagina, Recurrence, Postoperative complications, Mesh

XIANG Xue-bing, HU Qing, XIA Zhi-jun. Advantages and Complications of Transvaginal Mesh Surgery[J]. Journal of International Obstetrics and Gynecology, 2021, 48(2): 219-223.

References 30

[1]	Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse[J]. Int Urogynecol J, 2013,24(11):1783-1790. doi: 10.1007/s00192-013-2169-9. doi: 10.1007/s00192-013-2169-9 pmid: 24142054
[2]	Dällenbach P. To mesh or not to mesh: a review of pelvic organ reconstructive surgery[J]. Int J Womens Health, 2015,7:331-343. doi: 10.2147/IJWH.S71236. doi: 10.2147/IJWH.S71236 pmid: 25848324
[3]	Li Z, Xu T, Li Z, et al. An epidemiologic study of pelvic organ prolapse in rural Chinese women: a population-based sample in China[J]. Int Urogynecol J, 2019,30(11):1925-1932. doi: 10.1007/s00192-018-03859-9. doi: 10.1007/s00192-018-03859-9 pmid: 30685785
[4]	中华医学会妇产科学分会妇科盆底学组. 盆腔器官脱垂的中国诊治指南(2020年版)[J]. 中华妇产科杂志, 2020,55(5):300-306. doi: 10.3760/cma.j.cn112141-20200106-00016.
[5]	Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse[J]. Lancet, 2007,369(9566):1027-1038. doi: 10.1016/S0140-6736(07)60462-0. doi: 10.1016/S0140-6736(07)60462-0 pmid: 17382829
[6]	Delorme E. What transvaginal meshes (TVM) surgery tells us about conflicts of interest[J]. J Gynecol Obstet Hum Reprod, 2020,49(1):101636. doi: 10.1016/j.jogoh.2019.101636. doi: 10.1016/j.jogoh.2019.101636 pmid: 31520751
[7]	Duport C, Duperron C, Delorme E. Anterior and middle pelvic organ prolapse repair using a six tension-free strap low weight transvaginal mesh: long-term retrospective monocentric study of 311 patients[J]. J Gynecol Obstet Hum Reprod, 2019,48(3):143-149. doi: 10.1016/j.jogoh.2018.11.008. doi: 10.1016/j.jogoh.2018.11.008 pmid: 30508648
[8]	Luo DY, Yang TX, Shen H. Long term Follow-up of Transvaginal Anatomical Implant of Mesh in Pelvic organ prolapse[J]. Sci Rep, 2018,8(1):2829. doi: 10.1038/s41598-018-21090-w. doi: 10.1038/s41598-018-21090-w pmid: 29434209
[9]	King J. Real story behind transvaginal mesh[J]. Intern Med J, 2020,50(5):527-529. doi: 10.1111/imj.14831. doi: 10.1111/imj.14831 pmid: 32431034
[10]	范晓东. 女性盆底功能障碍性疾病的手术治疗进展[J]. 国际妇产科学杂志, 2019,46(1):27-31. doi: 10.3969/j.issn.1674-1870.2019.01.006.
[11]	Ray S, Clifton MM, Koo K. Inaccuracies in News Media Reporting About the 2019 US Food and Drug Administration Ban on Transvaginal Mesh for Pelvic Organ Prolapse Repair[J]. Urology,2020 May 18:S0090-4295(20)30553-7.. doi: 10.1016/j.urology.2020.05.009. Epub ahead of print. pmid: 33823174
[12]	Yassa M, Doğan O. The International Urogynecological Association/International Continence Society classification of complications of prosjournal and graft insertion: Pros and cons and a review of the literature[J]. J Turk Ger Gynecol Assoc, 2020,21(1):57-61. doi: 10.4274/jtgga.galenos.2019.2019.0036. doi: 10.4274/jtgga.galenos.2019.2019.0036 pmid: 31362485
[13]	Withagen MI, Vierhout ME, Hendriks JC, et al. Risk factors for exposure, pain, and dyspareunia after tension-free vaginal mesh procedure[J]. Obstet Gynecol, 2011,118(3):629-636. doi: 10.1097/AOG.0b013e31822ada95. pmid: 21860293
[14]	Ubertazzi EP, Soderini H, Saavedra Sanchez A, et al. Long-term outcomes of transvaginal mesh (TVM) In patients with pelvic organ prolapse: A 5-year follow-up[J]. Eur J Obstet Gynecol Reprod Biol, 2018,225:90-94. doi: 10.1016/j.ejogrb.2018.03.060. doi: 10.1016/j.ejogrb.2018.03.060 pmid: 29680466
[15]	Lo TS, Tan YL, Cortes EF, et al. Clinical outcomes of mesh exposure/extrusion: presentation, timing and management[J]. Aust N Z J Obstet Gynaecol, 2015,55(3):284-290. doi: 10.1111/ajo.12340. pmid: 26044791
[16]	Niu K, Lu YX, Shen WJ, et al. Risk Factors for Mesh Exposure after Transvaginal Mesh Surgery[J]. Chin Med J (Engl), 2016,129(15):1795-1799. doi: 10.4103/0366-6999.186631.
[17]	Allègre L, Callewaert G, Alonso S, et al. Long-term outcomes of a randomized controlled trial comparing trans-obturator vaginal mesh with native tissue repair in the treatment of anterior vaginal wall prolapse[J]. Int Urogynecol J, 2020,31(4):745-753. doi: 10.1007/s00192-019-04073-x. doi: 10.1007/s00192-019-04073-x pmid: 31506808
[18]	Veit-Rubin N, De Tayrac R, Cartwright R, et al. Abnormal vaginal microbiome associated with vaginal mesh complications[J]. Neurourol Urodyn, 2019,38(8):2255-2263. doi: 10.1002/nau.24129. doi: 10.1002/nau.24129 pmid: 31402478
[19]	Wu PY, Chang CH, Shen MR, et al. Seeking new surgical predictors of mesh exposure after transvaginal mesh repair[J]. Int Urogynecol J, 2016,27(10):1547-1555. doi: 10.1007/s00192-016-2996-6. pmid: 26992722
[20]	Dykes N, Karmakar D, Hayward L. Lightweight transvaginal mesh is associated with lower mesh exposure rates than heavyweight mesh[J]. Int Urogynecol J, 2020,31(9):1785-1791. doi: 10.1007/s00192-020-04270-z. doi: 10.1007/s00192-020-04270-z pmid: 32125493
[21]	Wei D, Wang P, Niu X, et al. Comparison between laparoscopic uterus/sacrocolpopexy and total pelvic floor reconstruction with vaginal mesh for the treatment of pelvic organ prolapse[J]. J Obstet Gynaecol Res, 2019,45(4):915-922. doi: 10.1111/jog.13908. doi: 10.1111/jog.13908 pmid: 30652385
[22]	Kamei J, Yazawa S, Yamamoto S, et al. Risk factors for surgical site infection after transvaginal mesh placement in a nationwide Japanese cohort[J]. Neurourol Urodyn, 2018,37(3):1074-1081. doi: 10.1002/nau.23416. doi: 10.1002/nau.23416 pmid: 29527737
[23]	Takahashi S, Obinata D, Sakuma T, et al. Tension-free vaginal mesh procedure for pelvic organ prolapse: a single-center experience of 310 cases with 1-year follow up[J]. Int J Urol, 2010,17(4):353-358. doi: 10.1111/j.1442-2042.2010.02469.x. doi: 10.1111/j.1442-2042.2010.02469.x pmid: 20202001
[24]	Hüsch T, Mager R, Ober E, et al. Quality of life in women of non-reproductive age with transvaginal mesh repair for pelvic organ prolapse: A cohort study[J]. Int J Surg, 2016,33 Pt A: 36-41. doi: 10.1016/j.ijsu.2016.07.062. pmid: 27465100
[25]	Gonocruz SG, Hayashi T, Tokiwa S, et al. Transvaginal surgery using self-cut mesh for pelvic organ prolapse: 3-year clinical outcomes[J]. Int J Urol, 2019,26(7):731-736. doi: 10.1111/iju.13984. pmid: 31066098
[26]	Kato K, Suzuki S, Kawanishi H, et al. POSTOPERATIVE CHRONIC PAIN FOLLOWING MESH AND NON-MESH REPAIR OF PELPIC ORGAN PROLAPSE[J]. Nihon Hinyokika Gakkai Zasshi, 2018,109(2):90-95. doi: 10.5980/jpnjurol.109.90. doi: 10.5980/jpnjurol.109.90 pmid: 31006747
[27]	Morselli S, Li Marzi V, Verrienti P, et al. Transvaginal mesh surgery for pelvic organ prolapse does not affect sexual function at long term follow up[J]. Eur J Obstet Gynecol Reprod Biol, 2019,240:282-287. doi: 10.1016/j.ejogrb.2019.07.027. doi: 10.1016/j.ejogrb.2019.07.027 pmid: 31352129
[28]	Jacquetin B, Fatton B, Rosenthal C, et al. Total transvaginal mesh (TVM) technique for treatment of pelvic organ prolapse: a 3-year prospective follow-up study[J]. Int Urogynecol J, 2010,21(12):1455-1462. doi: 10.1007/s00192-010-1223-0. pmid: 20683579
[29]	Oride A, Kanasaki H, Hara T, et al. Postoperative Outcomes Following Tension-Free Vaginal Mesh Surgery for Pelvic Organ Prolapse: A Retrospective Study[J]. Urol J, 2019,16(6):581-585. doi: 10.22037/uj.v0i0.4631. pmid: 31630387
[30]	Chughtai B, Mao J, Asfaw TS, et al. Long-term Device Outcomes of Mesh Implants in Pelvic Organ Prolapse Repairs[J]. Obstet Gynecol, 2020,135(3):591-598. doi: 10.1097/AOG.0000000000003689. doi: 10.1097/AOG.0000000000003689 pmid: 32028486